Attachment J10 - COVID19 Visitor Questionnaire at JL.docx

DOCX document 17 KB Posted

Attached to
NCTR Road & Drainage Improvements Federal contract opportunity
Solicitation number
FDA-RFP-75F40120R00012
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

About this file

This document contains a risk assessment questionnaire and requirements for visitors to the Jefferson Labs facility during the COVID-19 pandemic. The questionnaire requires visitors to provide their name and company, as well as details of their travel history, potential exposure to COVID-19, and current symptoms. It must be completed and returned within 24 hours prior to arrival by email to specified recipients at the FDA. All individuals entering the campus are mandated to wear face coverings.

A related federal contract opportunity involves road and drainage improvements at the National Center for Toxicological Research site. A Request for Proposal with number FDA-RFP-75F40120R00012 has been issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services. Attendees of any scheduled site visit must wear face coverings according to CDC guidelines or entry will be denied. Required attachments include CDC guidance on cloth face coverings.

View the file

Other files for this federal contract opportunity

Other files attached to NCTR Road & Drainage Improvements, newest first.
File Type Posted
Attachment J11 - 75F40120R00012 Section B through M Updates rev. 11-13-20.pdf PDF
75F40120R00012_0006.pdf PDF
Attachment J13 - Solar Powered Flagpole Lighting Specification.pdf PDF
Attachment J5 - Sample Client Letter 11-10-2020.pdf PDF
75F40120R00012_0005 Attachment 1 Site Visit 3 Minutes.pdf PDF
75F40120R00012_0005.pdf PDF
Attachment J12 - Drawing BKC-3615-F-801-16.pdf PDF
75F40120R00012_0005 Attachment 2 Site Visit 3 Questions Answers.pdf PDF
Attachment J11 - 75F40120R00012 Section B through M Updates rev. 10 Nov 20.pdf PDF
75F40120R00012_0004 Attachment 1 Site Visit 2 Minutes.pdf PDF
Attachment J11 - 75F40120R00012 Section B through M Updates rev. 29 Oct 20.pdf PDF
75F40120R00012_0004 Attachment 2 Site Visit 2 Questions Answers.pdf PDF
75F40120R00012_0004.pdf PDF
75F40120R00012_0003 Final.pdf PDF
Attachment J4 - US Department of Labor General Decicsion AR20200166 dtd. 5-1-2020.pdf PDF
75F40120R00012_0002 Final.pdf PDF
Attachment J5 - Sample Client Letter 10-9-2020.pdf PDF
Attachment J11 - 75F40120R00012 Section B through M Updates.pdf PDF
75F40120R00012_0001 Final.pdf PDF
75F40120R00012.pdf PDF
Attachment J7 - FDA Form 3398 Commitment to Protect Non-Public Information .pdf PDF
Attachment J3 - Cost Proposal Bid Schedule.pdf PDF
Attachment J4 - US Department of Labor General Decicsion AR20200166 dtd. 1-3-2020.pdf PDF
Attachment J9 - Certification of Current Arkansas State Contractors License.pdf PDF
Attachment J8 - HHS Subcontracting Plan Template.docx DOCX document
CDC - Cloth Face Covering Instructions.pdf PDF
Attachment J6 - Past Performance Evaluation Questionnaire.pdf PDF
Attachment J2 - Drawings.pdf PDF
Attachment J5 - Sample Client Letter.pdf PDF
Attachment J1 - Project Manual.pdf PDF
Show all 30

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Clinic Risk Assessment Questionnaire for Jefferson Labs (JL) Visitors Prior to their Arrival on Campus (Updated 20 May 2020) (One per visitor) Effective June 1, 2020 and until further notice, EVERYONE entering the campus is required to wear a face covering. No exceptions! Thank you for your cooperation.

Visitor’s Name/Company:

Name of JL staff (sponsor/escort) and Division/Contractor:

Name of the Approving Official:

1. Has the JL staff member received approval from the supervisor or Division Director for the visitor? YES or NO

2. The JL staff member must provide a statement stating why the visitor is essential:

Statement:

3. The visitor must provide his/her travel history for the past 3-weeks; within and/or outside of the United States

4. Has the visitor been in contact with, or within 6 feet of a person diagnosed with or suspected of having the coronavirus disease, or quarantined for coronavirus disease? YES or NO

5. Does the visitor have fever (greater than 100.4 degrees Fahrenheit), cough or shortness of breath? YES OR NO

If yes, please list your symptoms:

It is the responsibility of the JL staff to have your visitor complete and return this questionnaire within 24 hours prior to their arrival on center and email to: NCTROHU@fda.hhs.gov and Elvin.Sprankle@fda.hhs.gov Please notify the OHU if the answers to the questions change prior to entry to center at 870-543-7333

File details come from the government source that posted it. Updated .